Doxycycline and the treatment for bullous pemphigoid: what outcomes are most important to our patients?
Publication
, Journal Article
Cardones, AR; Hall, RP
Published in: Br J Dermatol
November 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Br J Dermatol
DOI
EISSN
1365-2133
Publication Date
November 2017
Volume
177
Issue
5
Start / End Page
1145 / 1147
Location
England
Related Subject Headings
- Prednisolone
- Pemphigoid, Bullous
- Humans
- Doxycycline
- Dermatology & Venereal Diseases
- Anti-Bacterial Agents
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Cardones, A. R., & Hall, R. P. (2017). Doxycycline and the treatment for bullous pemphigoid: what outcomes are most important to our patients? Br J Dermatol, 177(5), 1145–1147. https://doi.org/10.1111/bjd.15890
Cardones, A. R., and R. P. Hall. “Doxycycline and the treatment for bullous pemphigoid: what outcomes are most important to our patients?” Br J Dermatol 177, no. 5 (November 2017): 1145–47. https://doi.org/10.1111/bjd.15890.
Cardones AR, Hall RP. Doxycycline and the treatment for bullous pemphigoid: what outcomes are most important to our patients? Br J Dermatol. 2017 Nov;177(5):1145–7.
Cardones, A. R., and R. P. Hall. “Doxycycline and the treatment for bullous pemphigoid: what outcomes are most important to our patients?” Br J Dermatol, vol. 177, no. 5, Nov. 2017, pp. 1145–47. Pubmed, doi:10.1111/bjd.15890.
Cardones AR, Hall RP. Doxycycline and the treatment for bullous pemphigoid: what outcomes are most important to our patients? Br J Dermatol. 2017 Nov;177(5):1145–1147.
Published In
Br J Dermatol
DOI
EISSN
1365-2133
Publication Date
November 2017
Volume
177
Issue
5
Start / End Page
1145 / 1147
Location
England
Related Subject Headings
- Prednisolone
- Pemphigoid, Bullous
- Humans
- Doxycycline
- Dermatology & Venereal Diseases
- Anti-Bacterial Agents
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences